Advances in pediatric electrophysiology

Current Opinion in Pediatrics

Volumn 16, Issue 5, 2004, Pages 494-499

  Bevilacqua, Laura M ^b   Berul, Charles I ^a  

^a BOSTON CHILDREN S HOSPITAL   (United States)

^b NONE

Author keywords

Ablation; Congenital heart disease; Defibrillators; Pacemaker; Pediatric arrhythmias

Indexed keywords

ARTIFICIAL HEART PACEMAKER; CARDIOMYOPATHY; CATHETER ABLATION; CHILD; CONGENITAL HEART DISEASE; DEFIBRILLATOR; DEVICE; DISEASE ASSOCIATION; ELECTROPHYSIOLOGY; HEART ARRHYTHMIA; HEART ATRIUM PACEMAKER; HUMAN; MONITORING; PRIORITY JOURNAL; QT PROLONGATION; REVIEW; RISK ASSESSMENT; SYSTEMATIC REVIEW; TREATMENT OUTCOME;

ARRHYTHMIA; CARDIOMYOPATHY, HYPERTROPHIC; CHILD; CORTICAL SYNCHRONIZATION; DEATH, SUDDEN, CARDIAC; ELECTROCARDIOGRAPHY, AMBULATORY; ELECTROPHYSIOLOGY; HEART DEFECTS, CONGENITAL; HUMANS; MAGNETIC RESONANCE IMAGING;

EID: 4644307322     PISSN: 10408703     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.mop.0000137797.31436.04     Document Type: Review

References (27)

1. Saarel EV, Stefanelli CB, Fischbach PS, et al.: Transtelephonic electrocardiographic monitors for evaluation of children and adolescents with suspected arrhythmias. Pediatrics 2004, 113:248-251.
2. Rossano J, Bloemers B, Sreeram N, et al.: Efficacy of implantable loop recorders in establishing symptom-rhythm correlation in young patients with syncope and palpitations. Pediatrics 2003, 112:e228-e233. Implantable loop monitors provided symptom-rhythm correlation in patients with syncope, near-syncope, and palpitations, with and without structural heart disease after noninvasive means failed.
3. Razavi R, Hill DL, Keevil SF, et al.: Cardiac catheterization guided by MRI in children and adults with congenital heart disease. Lancet 2003, 372:1877-1882. MRI was used in combination with fluoroscopy to decrease radiation exposure and improve soft tissue visualization during cardiac catheterization of congenital heart disease patients.
4. Begley DA, Mohiddin SA, Tripodi D, et al.: Efficacy of implantable cardioverter defibrillator therapy for primary and secondary prevention of sudden cardiac death in hypertrophic cardiomyopathy. Pacing Clin Electrophysiol 2003, 26:1887-1896.
5. Alexander ME, Cecchin F, Walsh EP, et al.: Implications of implantable cardioverter defibrillator therapy in congenital heart disease and pediatrics. J Cardiovasc Electrophysiol 2004, 15:72-76.
6. DeMaso DR, Lauretti A, Spieth L, et al.: Psychosocial factors and quality of life in children and adolescents with implantable cardioverter- defibrillators. Am J Cardiol 2004, 93:582-587.
7. Monserrat L, Elliott PM, Gimeno JR, et al.: Non-sustained ventricular tachycardia in hypertrophic cardiomyopathy: an independent marker of sudden death risk in young patients. J Am Coll Cardiol 2003, 42:873-879.
8. Corrado D, Leoni L, Link MS, et al.: Implantable cardioverter- defibrillator therapy for prevention of sudden death in patients with arrhythmogenic right ventricular cardiomyopathy/dysplasia. Circulation 2003, 108:3084-3091.
9. Khositseth A, Martinez MW, Driscoll DJ, et al.: Syncope in children and adolescents and the congenital long QT syndrome. Am J Cardiol 2003,92:746-749.
10. Lupoglazoff JM, Denjoy I, Villain E, et al.: Long QT syndrome in neonates: conduction disorders associated with HERG mutations and sinus bradycardia with CKNQ1 mutations. J Am Coll Cardiol 2004, 43:826-830.
11. Tester DJ, McCormack J, Ackerman MJ: Prenatal molecular genetic diagnosis of congenital long QT syndrome by strategic genotyping. Am J Cardiol 2004, 93:788-791.
12. Etheridge SP, Compton SJ, Tristani-Firouzi M, et al.: A new oral therapy for long QT syndrome long-term oral potassium improves repolarization in patients with HERG mutations. J Am Coll Cardiol 2003, 42:1777-1782.
13. Dilawar M, Bradley SM, Saul JP, et al.: Sinus node dysfunction after intra-atrial lateral tunnel and extracardiac conduit Fontan procedures. Pediatr Cardiol 2003, 24:284-288.
14. Stephenson EA, Casavant D, Tuzi J, et al.: ATTEST investigators: Efficacy of atrial antitachycardia pacing using the Medtronic AT500 pacemaker in patients with congenital heart disease. Am J Cardiol 2003, 92:871-876. Atrial arrhythmia detection and antitachycardia pacing efficacy of the Medtronic AT500 pacemaker was evaluated in 28 patients with congenital heart disease and atrial arrhythmias. Antitachycardia pacing was successful in converting 54% of treatable episodes.
15. Weinstein S, Cua C, Chan D, et al.: Outcome of symptomatic patients undergoing extracardiac Fontan conversion and cryoablation. J Thorac Cardiovasc Surg 2003, 126:529-536. Ten patients undergoing Fontan revision surgery had empiric cryoablation and pacemaker implantation during the operation in an attempt to treat refractory atrial arrhythmias. Seven patients currently require no antiarrhythmic agents. Surgical mortality was 20%.
16. Kannankeril PJ, Anderson ME, Rottman JN, et al.: Frequency of late recurrence of intra-atrial reentry tachycardia after radiofrequency catheter ablation in patients with congenital heart disease. Am J Cardiol 2003, 92:879-881. Catheter ablation was performed in 40 patients with congenital heart disease and intraatrial reentry tachycardia. The acute success rate was 87%. Arrhythmia recurred in 34%.
17. Deal BJ, Mavroudis C, Backer CL: Beyond Fontan conversion: surgical therapy of arrhythmias including patients with associated complex congenital heart disease. Ann Thorac Surg 2003, 76:542-553; discussion 553-554.
18. Petko M, Myung RJ, Wernovsky G, et al.: Surgical reinterventions following the Fontan procedure. Eur J Cardiothorac Surg 2003, 42:185-196.
19. Collins KK, Rhee EK, Delucca JM, et al.: Modification to the Fontan procedure for the prophylaxis of intra-atrial reentrant tachycardia: short-term results of a prospective randomized blinded trial. J Thorac Cardiovasc Surg 2004, 127:721-729.
20. Zimmerman FJ, Starr JP, Koenig PR, et al.: Acute hemodynamic benefit of multisite ventricular pacing after congenital heart surgery. Ann Thorac Surg 2003, 75:1775-1780. Twenty-nine patients with congenital heart disease and a wide QRS complex underwent multisite ventricular pacing for cardiac resynchronization. Multisite pacing led to improved cardiac index and increased systolic blood pressure.
21. Bristow MR, Saxon LA, Boehmer J, et al.: Cardiac resynchronization therapy with or without an implantable defibrillator in advanced chronic heart failure. N Engl J Med 2004, 350:2140-2150.
22. Auricchio A: Beyond the measurement of QRS complex toward mechanical dyssynchrony: cardiac resynchronisation therapy in heart failure patients with normal QRS duration. Heart 2004, 90:479-481.
23. Turner MS, Bleasdale RA, Mumford CE, et al.: Left ventricular pacing improves haemodynamic variables in patients with heart failure with a normal QRS duration. Heart 2004, 90:502-505.
24. Janousek J, Tomek V, Chaloupecky V, et al.: Dilated cardiomyopathy associated with dual-chamber pacing in infants: improvement through either left ventricular cardiac resynchronization or programming the pacemaker off allowing intrinsic normal conduction. J Cardiovasc Electrophysiol 2004, 15:470-474.
25. Roofthooft MT, Blom NA, Rijilaarsdam ME, et al.: Resynchronization therapy after congenital heart surgery to improve left ventricular function. Pacing Clin Electrophysiol 2003, 26:2042-2044.
26. Dubin AM, Feinstein JA, Reddy VM, et al.: Electrical resynchronization: a novel therapy for the failing right ventricle. Circulation 2003, 107:2287-2289. Seven patients with right ventricular dysfunction and right bundle branch block had improved RV performance during atrioventricular pacing with RV resynchronization.
27. Stephenson EA, Cecchin F, Alexander ME, et al.: Relation of right ventricular pacing in tetralogy of Fallot to electrical resynchronization. Am J Cardiol 2004, 93:1449-1452.